Early diagnosis of melanoma using expression profiling and non-invasive sampling of skin cells in adults with a pigmented lesion suspected of being a melanoma

Dermtech International0 个研究点目标入组 300 人开始时间: 2012年5月10日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•The subject will be eligible if he or she:
•(i) Is at least 18 years of age;
•(ii) Has a pigmented lesion that is suspected of being a melanoma and requires surgical removal with a preoperative biopsy diameter of greater than and/or equal to 4 mm. Multiple lesions must be at least 4 mm apart;
•(iii) The subject is willing to follow standard of care provided by the investigator and/or designee.

•The subject cannot participate in this study if he or she:
•(i) Has used topical medications (corticosteroids, alpha-hydroxyacids, retinoids, antibiotics) or systemic steroids within 30 days of beginning the research study;
•(ii) Has generalized skin disorders not related to skin cancer such as psoriasis, photosensitivity disorder or eczema;
•(iii) Has allergy to tape or latex rubber;
•(iv) Subject is currently participating, or has participated in the 30 days prior to study, in an investigational (OTC, RX or device) study;
•(v) Has used sun screen and/or moisturizer within 24 hours of study entry;
•(vi) Subject with other abnormal clinical findings which the Investigator feels may put the Subject at undue risk or may interfere with the study results.
•(vii) Has an advanced stage lesion (e.g. ulcerated, bleeding, oozing).

发起方